Related Experiment Video
Updated: Jul 24, 2026
05:03
Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
Published on: October 28, 2022
1.2K
[Research progress on pneumoconiosis markers based on multi-omics analysis].
1Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, Nantong 226019, China.
Summary
Identifying new markers for pneumoconiosis (lung fibrosis from dust) is crucial. Multi-omics approaches offer a promising strategy for early diagnosis and developing effective treatments for this condition.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Genomics
Background:
- The causes of pneumoconiosis are known, but its disease mechanisms and effective cures remain unclear.
- Pulmonary fibrosis, a hallmark of pneumoconiosis, necessitates better diagnostic and therapeutic strategies.
- Early identification of high-risk individuals and intervention targets are critical for managing dust-related lung diseases.
Purpose of the Study:
- To review the progress in identifying pneumoconiosis markers using multi-omics.
- To highlight the potential of multi-omics for understanding disease pathogenesis and developing interventions.
- To provide foundational data for early prevention, diagnosis, and treatment of pneumoconiosis.
Main Methods:
- Review of current research on pneumoconiosis markers.
- Exploration of multi-omics technologies including genomics, transcriptomics, and proteomics.
- Discussion of future directions involving integrated multi-omics and multi-stage analyses.
Main Results:
- Multi-omics provides novel avenues for discovering potential pneumoconiosis biomarkers.
- Systematic analysis of multi-omics data can identify key genes, proteins, and metabolic pathways.
- Development of core regulatory networks can aid in screening for sensitive diagnostic and therapeutic markers.
Conclusions:
- Multi-omics approaches are essential for a comprehensive understanding of pneumoconiosis pathogenesis.
- Identifying key molecular players and networks can lead to sensitive markers for early diagnosis and treatment.
- Further research combining multi-omics data is vital for advancing pneumoconiosis management.
Keywords:
GenomicsMarkersMetabolomicsPneumoconiosisProteomicsRibonucleic acidSilicosisSingle nucleotide polymorphism, SNPsTranscriptomicsMore Related Videos
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...